The pharmaceutical industry widely uses antibodies to create drugs, such as for cancer and coronaviruses. But creating the ...

Recent scientific advancements have led to the development of a nanotechnology-based cancer drug that is 20,000 times more potent than its predecessors, yet remarkably, it exhibits no detectable side ...

The draft guidance, which is touted as a way to reduce the cost and time-associated burden of biosimilar development, has ...

It's the latest stride by Nvidia and the pharmaceutical industry to harness AI to try to reduce costs and shorten the time it ...

The Food and Drug Administration (FDA) development and approval process for drugs and medical devices involves multiple phases that ensure the safety and effectiveness of products before and after ...

IIT Madras announces the 'PURE' AI framework, promising significant reductions in drug development timelines. Developed with Ohio State University, PURE uses reinforcement learning to optimize ...

WASHINGTON (7News) — Artificial intelligence is poised to dramatically reshape the process of developing and approving new medicines, according to industry experts. Traditionally, the path from drug ...

Sai Life Sciences announces the groundbreaking of a state-of-the-art CMC Process R&D Center in Hyderabad, poised to double ...

The Lupus Research Alliance (LRA), through its Lupus Accelerating Breakthroughs Consortium (Lupus ABC)—a public-private ...

Company highlights its global expertise and new and expanded capabilities to help biopharma and biotech customers solve global health challenges Thermo Fisher Scientific Inc., the world leader in ...